Double blind, placebo-controlled, efficacy and safety study of clobazam in patients with Lennox-Gastaut syndrome.
Phase of Trial: Phase III
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Clobazam (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Registrational; Therapeutic Use
- Acronyms CONTAIN
- Sponsors Lundbeck Inc
- 28 Sep 2016 Results of post-hoc analysis from OV-1004 and OV-1012 studies (n=200) published in the Neurology.
- 04 May 2016 Post hoc analysis results published in the Epilepsia
- 03 May 2014 Results from a post-hoc sub-analysis for modified intention-to-treat patients versus patients who completed all 15 weeks presented at the 66th Annual Meeting of the American Academy of Neurology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History